394 related articles for article (PubMed ID: 28394416)
1. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.
Kim A; Han JY; Ryu CM; Yu HY; Lee S; Kim Y; Jeong SU; Cho YM; Shin DM; Choo MS
Histopathology; 2017 Sep; 71(3):415-424. PubMed ID: 28394416
[TBL] [Abstract][Full Text] [Related]
2. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
Jhang JF; Hsu YH; Kuo HC
Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
[TBL] [Abstract][Full Text] [Related]
3. Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation.
Maeda D; Akiyama Y; Morikawa T; Kunita A; Ota Y; Katoh H; Niimi A; Nomiya A; Ishikawa S; Goto A; Igawa Y; Fukayama M; Homma Y
PLoS One; 2015; 10(11):e0143316. PubMed ID: 26587589
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
5. Pathology and terminology of interstitial cystitis/bladder pain syndrome: A review.
Akiyama Y; Homma Y; Maeda D
Histol Histopathol; 2019 Jan; 34(1):25-32. PubMed ID: 30015351
[TBL] [Abstract][Full Text] [Related]
6. Digital quantitative analysis of mast cell infiltration in interstitial cystitis.
Akiyama Y; Maeda D; Morikawa T; Niimi A; Nomiya A; Yamada Y; Igawa Y; Goto A; Fukayama M; Homma Y
Neurourol Urodyn; 2018 Feb; 37(2):650-657. PubMed ID: 29065222
[TBL] [Abstract][Full Text] [Related]
7. Phenotyping of interstitial cystitis/bladder pain syndrome.
Akiyama Y; Hanno P
Int J Urol; 2019 Jun; 26 Suppl 1():17-19. PubMed ID: 31144756
[TBL] [Abstract][Full Text] [Related]
8. Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.
Akiyama Y; Niimi A; Nomiya A; Yamada Y; Nakagawa T; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
Neurourol Urodyn; 2018 Apr; 37(4):1441-1447. PubMed ID: 29315774
[TBL] [Abstract][Full Text] [Related]
9. Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome.
Whitmore KE; Fall M; Sengiku A; Tomoe H; Logadottir Y; Kim YH
Int J Urol; 2019 Jun; 26 Suppl 1():26-34. PubMed ID: 31144757
[TBL] [Abstract][Full Text] [Related]
10. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?
Gamper M; Regauer S; Welter J; Eberhard J; Viereck V
J Urol; 2015 Jun; 193(6):1994-2000. PubMed ID: 25596361
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion.
Choi D; Han JY; Shin JH; Ryu CM; Yu HY; Kim A; Lee S; Lim J; Shin DM; Choo MS
Sci Rep; 2018 Jun; 8(1):9782. PubMed ID: 29955137
[TBL] [Abstract][Full Text] [Related]
12. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
Lee CL; Jiang YH; Kuo HC
BJU Int; 2013 Dec; 112(8):1156-62. PubMed ID: 23937072
[TBL] [Abstract][Full Text] [Related]
13. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.
Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y
Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459
[TBL] [Abstract][Full Text] [Related]
14. Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: Long-term outcomes and prognostic predictors.
Niimi A; Nomiya A; Yamada Y; Suzuki M; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
Neurourol Urodyn; 2016 Nov; 35(8):965-969. PubMed ID: 26208131
[TBL] [Abstract][Full Text] [Related]
15. Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells.
Logadottir Y; Hallsberg L; Fall M; Peeker R; Delbro D
Scand J Urol; 2013 Feb; 47(1):52-6. PubMed ID: 22775390
[TBL] [Abstract][Full Text] [Related]
16. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
[TBL] [Abstract][Full Text] [Related]
17. Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition.
Jhang JF; Ho HC; Jiang YH; Lee CL; Hsu YH; Kuo HC
PLoS One; 2018; 13(6):e0198816. PubMed ID: 29879217
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of self-reported nocturia in patients with interstitial cystitis, and effects of bladder hydrodistention (with fulguration of Hunner lesions) on nocturia.
Otsuka A; Suzuki T; Aki R; Matsushita Y; Tamura K; Motoyama D; Ito T; Sugiyama T; Miyake H
Low Urin Tract Symptoms; 2019 Apr; 11(2):O141-O146. PubMed ID: 30010251
[TBL] [Abstract][Full Text] [Related]
19. Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome.
Ueda T; Hanno PM; Saito R; Meijlink JM; Yoshimura N
Int Neurourol J; 2021 Jun; 25(2):99-110. PubMed ID: 34218637
[TBL] [Abstract][Full Text] [Related]
20. Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients.
Kamasako T; Kaga K; Inoue KI; Hariyama M; Yamanishi T
Int J Urol; 2022 May; 29(5):406-412. PubMed ID: 35102612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
